Mode
Text Size
Log in / Sign up

SinglePass Kronos device shows promise for liver biopsy tract closure in small series

SinglePass Kronos device shows promise for liver biopsy tract closure in small series
Photo by Dmytro Vynohradov / Unsplash
Key Takeaway
Consider this device as a potential option for liver biopsy tract closure, but recognize the evidence is limited to a small, non-comparative series.

A retrospective, observational case report series evaluated the SinglePass Kronos electrocautery device for closing the biopsy tract after percutaneous liver mass biopsies in a small cohort of patients. The primary focus was on achieving hemostasis and tract closure, with secondary attention to bleeding complications and post-procedure imaging.

The authors reported that all biopsy procedures were technically successful. Over a 30-day follow-up period, they observed no complications, including an absence of bleeding. The series noted no serious adverse events or discontinuations related to the device.

Key limitations highlighted by the authors include the very small sample size and the non-comparative design, which preclude any conclusions about efficacy versus standard techniques. The findings are from a single-center experience without a control group.

Clinically, the authors suggest the device may be a valuable tool for minimizing bleeding in percutaneous solid organ biopsies, particularly in high-risk scenarios like liver masses. However, they caution that large-scale studies are warranted to confirm these preliminary observations and establish broader relevance.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Percutaneous liver mass biopsies, including coaxial needle biopsy (CNB), have become the preferred method for obtaining tissue samples in diagnosing or characterizing liver masses. Despite the advent of intraprocedural computed tomography (CT) and/or ultrasound image guidance as well as various biopsy tract “plugging” techniques, bleeding remains a frequent and potentially highly morbid complication. As such, patients often undergo extended monitoring. Furthermore, in cases of bleeding, patients may require additional imaging, intervention, and even surgery. Death, while very rare, is known to occur. We report a retrospective, observational, non-comparative series of five image-guided liver mass biopsy cases in which hemostasis and biopsy tract closure were obtained with a new electrocautery hemostasis device called the SinglePass Kronos electrocautery device. All biopsy procedures were technically successful, and there were no reported complications out to 30 days. Post-procedure imaging confirmed the absence of bleeding in all five cases. The SinglePass electrocautery device is a potentially valuable tool in minimizing bleeding complications in percutaneous solid organ biopsy procedures and has particular utility in high-risk biopsies such as liver mass biopsies. Larger-scale studies of this new device may be warranted.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.